OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Treating Advanced Renal Cell Carcinoma

home / peer-exchange / advanced-renal-cell-carcinoma
Treatment Options in Renal Cell Carcinoma

EP. 1: Treatment Options in Renal Cell Carcinoma

February 4th 2016
Pazopanib and Sunitinib in Renal Cell Carcinoma

EP. 2: Pazopanib and Sunitinib in Renal Cell Carcinoma

February 4th 2016
Dosing Schedule of Sunitinib in Renal Cell Carcinoma

EP. 3: Dosing Schedule of Sunitinib in Renal Cell Carcinoma

February 4th 2016
Treating Non-Clear Cell Histologies of RCC

EP. 4: Treating Non-Clear Cell Histologies of RCC

February 4th 2016
Combination Therapies in Renal Cell Carcinoma

EP. 5: Combination Therapies in Renal Cell Carcinoma

February 4th 2016
Defining Disease Progression in Renal Cell Carcinoma

EP. 6: Defining Disease Progression in Renal Cell Carcinoma

February 4th 2016
Study Results of Nivolumab in Renal Cell Carcinoma

EP. 7: Study Results of Nivolumab in Renal Cell Carcinoma

February 4th 2016
Managing Checkpoint Inhibitor Therapy in RCC

EP. 8: Managing Checkpoint Inhibitor Therapy in RCC

February 4th 2016
Sequencing Renal Cell Carcinoma Therapies

EP. 9: Sequencing Renal Cell Carcinoma Therapies

February 4th 2016
The Role of Lenvatinib and Cabozantinib in RCC

EP. 10: The Role of Lenvatinib and Cabozantinib in RCC

February 4th 2016
Sequencing Metastatic Renal Cell Carcinoma Treatments

EP. 11: Sequencing Metastatic Renal Cell Carcinoma Treatments

February 4th 2016
Future Expectations in Renal Cell Carcinoma

EP. 12: Future Expectations in Renal Cell Carcinoma

February 4th 2016

Latest Conference Coverage

Tucatinib/Trastuzumab Yields Durable Responses in HER2-Mutated Metastatic Breast Cancer

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact